Four Rivers Clinical Research

Paducah, Kentucky 42003

0 studies enrolling now · 26 studies all time

What they study most

ADHD, ADHD Specifically With Executive Function Impairment, Alzheimer Disease, Alzheimer's Disease, Anxiety Disorder, Anxiety Disorders, Attention Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder, Attention-deficit/Hyperactivity Disorder, Benign Prostatic Hypertrophy, Cervical Neoplasms, Chronic Kidney Disease (CKD)

Studies at this site

• Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention — Completed
• Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease — Completed
• A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment — Stopped early
• Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder — Completed
• SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms — Completed
• Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) — Completed
• Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder — Completed
• Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens — Completed
• Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease — Completed
• The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility — Completed
• Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) — Stopped early
• Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens — Completed
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM — Completed
• Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain — Completed
• Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder. — Completed
• A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD — Completed
• A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia — Completed
• Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) — Completed
• Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease — Stopped early
• A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil — Stopped early
• Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD) — Completed
• A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy — Stopped early
• 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type — Completed
• Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes — Status unconfirmed